138 related articles for article (PubMed ID: 36595382)
21. Non-conventional laryngeal malignancies: a multicentre review of management and outcomes.
O'Neill RJ; Hintze J; Sharifah A; Garry S; Woods G; Noone A; Barrett HL; Young O; Mamdouh S; Shine N; Timon C; Kinsella J; Sheahan P; Lennon P; O'Neill JP
Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3383-3392. PubMed ID: 37005958
[TBL] [Abstract][Full Text] [Related]
22. Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
Peretti G; Piazza C; Penco S; Santori G; Del Bon F; Garofolo S; Paderno A; Guastini L; Nicolai P
Head Neck; 2016 Jul; 38(7):1107-12. PubMed ID: 26970262
[TBL] [Abstract][Full Text] [Related]
23. Staging and survival analysis for nonsquamous cell carcinomas of the larynx.
Lin HW; Bhattacharyya N
Laryngoscope; 2008 Jun; 118(6):1003-13. PubMed ID: 18388773
[TBL] [Abstract][Full Text] [Related]
24. Laryngeal Dysplasia, Squamous Cell Carcinoma, and Variants.
Thompson LD
Surg Pathol Clin; 2017 Mar; 10(1):15-33. PubMed ID: 28153131
[TBL] [Abstract][Full Text] [Related]
25. Treatment and Survival Trends in Glottic Carcinoma in Situ and Stage I Cancer From 1988 to 2012.
Khaja SF; Hoffman HT; Pagedar NA
Ann Otol Rhinol Laryngol; 2016 Apr; 125(4):311-6. PubMed ID: 26481178
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma.
Graboyes EM; Townsend ME; Kallogjeri D; Piccirillo JF; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1154-1163. PubMed ID: 27435696
[TBL] [Abstract][Full Text] [Related]
27. WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer.
Tiefenböck-Hansson K; Haapaniemi A; Farnebo L; Palmgren B; Tarkkanen J; Farnebo M; Munck-Wikland E; Mäkitie A; Garvin S; Roberg K
Oncol Rep; 2017 Oct; 38(4):2062-2068. PubMed ID: 28849066
[TBL] [Abstract][Full Text] [Related]
28. Evidence-based practice: management of glottic cancer.
Hartl DM
Otolaryngol Clin North Am; 2012 Oct; 45(5):1143-61. PubMed ID: 22980690
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus-associated squamous cell carcinoma of the larynx or hypopharynx: Clinical outcomes and implications for laryngeal preservation.
Hughes RT; Beuerlein WJ; O'Neill SS; Porosnicu M; Lycan TW; Waltonen JD; Frizzell BA; Greven KM
Oral Oncol; 2019 Nov; 98():20-27. PubMed ID: 31536842
[TBL] [Abstract][Full Text] [Related]
30. Incidence of and survival after glottic squamous cell carcinoma in Denmark from 1971 to 2011-A report from the Danish Head and Neck Cancer Group.
Lyhne NM; Johansen J; Kristensen CA; Andersen E; Primdahl H; Andersen LJ; Oksbjerg S; Overgaard J
Eur J Cancer; 2016 May; 59():46-56. PubMed ID: 27014799
[TBL] [Abstract][Full Text] [Related]
31. Secondary Squamous Cell Carcinoma of the Oral Cavity after Nasopharyngeal Carcinoma.
Dai L; Fang Q; Li P; Wu J; Zhang X
Cancer Res Treat; 2020 Jan; 52(1):109-116. PubMed ID: 31163959
[TBL] [Abstract][Full Text] [Related]
32. T1 squamous cell carcinoma of the glottis with anterior commissure involvement: Radiotherapy versus transoral laser microsurgery.
Alkan U; Nachalon Y; Shkedy Y; Yaniv D; Shvero J; Popovtzer A
Head Neck; 2017 Jun; 39(6):1101-1105. PubMed ID: 28371063
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity.
Mohan S; Pai SI; Bhattacharyya N
Laryngoscope; 2017 Jun; 127(6):1334-1338. PubMed ID: 28150306
[TBL] [Abstract][Full Text] [Related]
34. Radiation vs surgery for early-stage laryngeal verrucous carcinoma: A population-based propensity score matched-study.
Takenaka Y; Uno A; Tanaka H; Takemoto N; Nozaki K; Inohara H
PLoS One; 2022; 17(10):e0275271. PubMed ID: 36315501
[TBL] [Abstract][Full Text] [Related]
35. Basaloid squamous cell carcinoma of the head and neck: location means everything.
Fritsch VA; Lentsch EJ
J Surg Oncol; 2014 May; 109(6):616-22. PubMed ID: 24464879
[TBL] [Abstract][Full Text] [Related]
36. T1-2 glottic cancer treated with radiotherapy and/or surgery.
Shelan M; Anschuetz L; Schubert AD; Bojaxhiu B; Dal Pra A; Behrensmeier F; Aebersold DM; Giger R; Elicin O
Strahlenther Onkol; 2017 Dec; 193(12):995-1004. PubMed ID: 28474090
[TBL] [Abstract][Full Text] [Related]
37. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
[TBL] [Abstract][Full Text] [Related]
38. Transoral laser microsurgery for T1a glottic cancer: review of 404 cases.
Canis M; Ihler F; Martin A; Matthias C; Steiner W
Head Neck; 2015 Jun; 37(6):889-95. PubMed ID: 24623709
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy.
Pai HH; Rochon L; Clark B; Black M; Shenouda G
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):37-42. PubMed ID: 9588915
[TBL] [Abstract][Full Text] [Related]
40. miR-19a and SOCS-1 expression in the differential diagnosis of laryngeal (glottic) verrucous squamous cell carcinoma.
Marioni G; Agostini M; Cappellesso R; Bedin C; Ottaviano G; Marchese-Ragona R; Lovato A; Cacco T; Giacomelli L; Nitti D; Blandamura S; Stellini E; de Filippis C
J Clin Pathol; 2016 May; 69(5):415-21. PubMed ID: 26502748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
